FRANKFURT, Germany (AP) — Bundesliga club Eintracht Frankfurt has signed French striker Elye Wahi on a long-term deal until 2030.
Frankfurt posted a photo on X of the 22-year-old Wahi putting pen to paper on Friday evening.
“I'm very happy to have signed for Eintracht Frankfurt," Wahi said in French. “I hope the supporters of the club have faith in me and that I will repay them.”
No transfer fee was given but French website L'Equipe reported that Frankfurt paid 26 million euros ($27.3 million) for Wahi with an additional 3 million euros in bonuses and a 12% share of any future sell-on profit.
It is the third significant career move in two years for Wahi, who joined Lens from Montpellier in 2023 for a fee of 35 million euros ($38 million), turning down Premier League side Chelsea.
Despite a bright start at Lens he failed to settle and, after scoring 12 goals in 36 games, he joined Marseille this season for 25 million euros. But he scored only three league goals for the club and struggled for consistency.
Wahi made a strong impression with Montpellier in the 2022-23 season, scoring 19 league goals and impressing with his speed and skill.
Frankfurt has sold two forwards for big profits, with Randal Kolo Muani joining Paris Saint-Germain in 2023 in a deal worth 95 million euros and Egypt forward Omar Marmoush joining Premier League champion Manchester City on Thursday for a reported 70 million euros ($73 million).
AP soccer: https://apnews.com/hub/soccer
FILE - Lens' Elye Wahi celebrates after scoring his side' second goal during the French League One soccer match between Lyon and Lens at the Groupama stadium, outside Lyon, France, Sunday, March 3, 2024. (AP Photo/Laurent Cipriani, File)
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--
ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/
“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”
Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.
In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.
“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.
About ChemWerth, Inc.:
Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.
Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.
